"Potent immunotherapy against well-established thymoma using adoptively transferred transgene IL-6-engineered dendritic cell-stimulated CD8+ T-cells with prolonged survival and enhanced cytotoxicity"
Authors: Kalyanasundaram Bhanumathy K, Zhang B, Xie Y, Xu A, Tan X, Xiang J.
J Gene Med. 2015 Aug-Sep;17(8-9):153-60. PMID: 26212685
The paper can be accessed here: http://www.ncbi.nlm.nih.gov/pubmed/26212685
Share this story